Hospitals discharge considerable amounts of chemicals and microbial agents in their wastewaters. Problem chemicals present in hospital wastewater belong to different groups, such as antibiotics, X-ray contrast agents, disinfectants and pharmaceuticals. Many of these chemical compounds resist normal wastewater treatment. They end up in surface waters where they can influence the aquatic ecosystem and interfere with the food chain. Humans are particularly exposed by the drinking water, produced from surface water. Microbial agents of special concern are multiresistant microbial strains. The latter are suspected to contribute to the spread of antibiotic resistance. In this paper, we will discuss the different approaches towards hospital wastewater treatment. The principle of uncoupling hospitals from public sewers warrants indepth evaluation by technologists and ecotoxicologists as well as public health specialists.
INTRODUCTION
Hospital wastewater constitutes a major discharge of chemicals, but it is not unique in this respect. Residues of pharmaceuticals can be found in all wastewater treatment plant (WWTP) effluents, due to their inefficient removal in the conventional systems (Kü mmerer 2001; Kolpin et al. 2002; Petrovic et al. 2003; Snyder et al. 2003; Carballa et al. 2004 ). It is difficult to distinguish between pharmaceuticals which originate from hospitals connected to the sewer and from household users. For substances such as iodinated X-ray contrast media, which are used for X-ray imaging of soft tissues, the hospital source is obvious. Non-prescription drugs are mainly used in hospitals (Kolpin et al., 2002) , but in households as well.
Besides recalcitrant and potent chemicals, hospitals discharge plenty of undesired potentially pathogenic propagules, e.g. antibiotic resistant bacteria, viruses and maybe even prions, etc. There may arise situations where a total exclusion of emission from the hospital is required, for instance in the case of multiple antibiotic-resistant strains (MARS) .
In this review, we pose the question "Can public policy continue to allow co-treatment of hospital wastewater with domestic sewage?" To evaluate this topic, an array of chemicals is scrutinized (Table 1 ) and potentially pathogenic propagules discharged by hospitals are reviewed. In the second section, emission abatement scenarios and their respective costs are examined.
EMISSION OF CHEMICALS Chemicals
The presence of chemicals in wastewaters, surface waters, drinking waters and groundwaters has been reviewed extensively (Daughton & Ternes 1999; Jones et al. 2001;  major use in hospital practice), platinum, mercury (in preservatives in diagnostic agents and as active ingredients of disinfectants), rare earth elements (gadolinium, indium, osmium) and iodinated X-ray contrast media (Kü mmerer 2001) . Other pharmaceuticals which have been detected in WWTP effluents include lipid regulators, analgesics, antibiotics (cf. above), antidepressants, antiepileptics, antineoplastics, antipyretics, antiphlogistics, antirheumatics, b-blockers, broncholytics, b2-sympathomimetics, estrogens (cf. below), secretolytics, vasodilators and X-ray contrast media (cf. below) (Sacher et al. 2001; Ternes 2001) .
Antibiotics
About 10 A lot of researchers focussed on the presence of antibiotics in surface waters and/or its implications for drinking water production technology (Sacher et al. 2001; Snyder et al. 2003) . Webb et al. (2003) evaluated the risk of indirect exposure via drinking water of pharmaceuticals.
For the most part of pharmaceuticals and in casu for antibiotics, at the present levels in drinking water prepared from surface waters there appears no risk in consuming 2 L of water daily during a lifetime of 70 years. and E3 can be expected. However, to the best of our knowledge, hospital wastewater estrogen levels have not been reported.
Other chemicals
The antimanic/antiepileptic drug carbamazepine has a chronic toxicity down to 25 mg/L on ceriodaphnids (toxicity test organisms). Risk quotients calculated for French and German WWTP effluents are greater than unity, thus meaning that these effluents pose a threat for aquatic life.
This finding is corroborated by the fact that there is a continuous input of drugs in the environment, hence yielding chronic toxicity effects (Ferrari et al. 2003 ). Cytostatic agents represent a danger because of their proven carcinogenicity, mutagenicity and embryotoxic properties. The largest emission of platinum stems from its use as a cytostatic agent. In this respect, the major source is excretion by patients (ng/L to mg/L levels in urine).
Gadolinium (Gd) and recently indium (In) complexes are used in MRI (magnetic resonance imaging). These Gd and
In complexes are non-biodegradable.
EMISSION OF PROPAGULES

Antibiotic resistant propagules
Bacteria have different mechanisms to become resistant to a specific antibiotic. Genes encoding for this resistance can be transferred vertically (i.e. to the bacteria's offspring) or horizontally (i.e. among bacteria of different taxonomic affiliation) (Schwartz et al. 2003) . (Resistance) gene transfer is optimal at high cell densities and under high selective pressure (i.e. high antibiotic concentrations). However, under heterogeneous environmental conditions, this gene transfer can still occur at a significant level (van Elsas et al.
2000)
.
The emergence and spread of methicillin-resistant
Staphylococcus aureus (MRSA) is of special concern.
MRSA strains acquire multiresistance by means of additional resistant factors, such as conjugative gentamycin resistance plasmids (Ohlsen et al. 2003 These studies clearly demonstrate that hospital wastewaters are a source of bacteria with acquired resistance against antibiotics and this with at least a factor of 2 -10 higher than domestic wastewater.
EMISSION ABATEMENT OF CHEMICALS
Removal efficiencies of different wastewater treatment techniques are commented on in the following paragraphs.
A summary can be found in Table 2 . For hospitals having their own on-site wastewater treatment plant, i.e. they do not discharge their raw wastewater into the sewer, data for chemical concentrations and/or chemical removal are not available in the literature.
Antibiotics
There are several options for antibiotic removal out of (hospital) wastewater. 
Iodinated contrast media (ICMs)
Activated sludge treatment is inefficient in removing ICMs. Carballa et al. (2004) detected no removal of iopromide in a .
Costs of the required application of 10 g O 3 /m 3 wastewater were estimated to be lower than 0.04 e/m 3 . Larsen et al. Photolysis of E1 and E2 has been demonstrated with an UV (ultraviolet) disinfection lamp and a high pressure mercury lamp. The breakdown mechanism includes an oxidation of benzene rings to produce compounds containing a carbonyl group (Liu & Liu 2004 ).
Due to the oxidizing effect of chlorine, chlorination reduces the estrogenic potency of E2-containing solutions.
However, disinfection byproducts were formed (Lee et al. 2004 
Other chemicals
Biodegradation of four relevant pharmaceuticals (the antiphlogistic diclofenac, the antiepileptic carbamazepine and the lipid regulators clofibric acid and bezafibrate) is assumed to be relatively low (Ternes et al. 2002) . However, other factors should be considered since Clara et al. (2004) found . 95% removal of bezafibrate and the analgesic ibuprofen in both AS and MBR systems. Carbamazepine
was not removed at all in these systems. Diclofenac showed a more differentiated behavior in the treatment plants. In the conventional AS plant 40 -60% removal was obtained, whereas in the MBR system, removal efficiency was dependent on the sludge residence time (SRT). With a SRT .10 d, similar results were obtained as in the AS plant.
Flocculation with iron (III) chloride does not remove any of these four pharmaceuticals (diclofenac, carbamazepine, clofibric acid and bezafibrate) significantly, neither does slow sand filtration. GAC, in contrast, succeeded very well in removing the selected compounds (Ternes et al. 2002) .
Ozonation was very effective in removing carbamazepine and diclofenac, decreased bezafibrate and primidone concentration levels considerably, but removed clofibric acid only to a limited extent . In addition, Huber The authors showed that the hospital was the only contributor to the multiple antibiotic resistance. Chlorination was necessary; especially to inactivate the 7.5 £ 10 3 CFU of multiple antibiotic resistant strains (MARS) per mL of wastewater.
After chlorination no MARS could be detected. Chlorination with sodium hypochlorite has been linked to AOX (adsorbable organic halogens) by Emmanuel et al. (2004) . The authors found a positive correlation between these AOX (adsorbable organic halogens) in hospital wastewater and toxicity on Daphnia magna.
CRITICAL ISSUES
Hospital wastewaters urgently merit to be addressed as critical discharges to the environment in both developing and industrialized countries. In view of the above mentioned features, it is clear that hospital wastewater is a complex matrix which warrants treatment before discharge to the environment.
Four scenarios for hospital wastewater treatment can be envisioned: (1) direct discharge to the environment, (2) cotreatment in a municipal WWTP, (3) on-site wastewater treatment and subsequent discharge of the effluent to the environment, and finally (4) first on-site and subsequently municipal wastewater treatment. These scenarios are schematized in Figure 1 . To the best of our knowledge, data on the occurrence of these different types of treatment 
Membrane bioreactors (MBRs)
Membrane bioreactors have been proposed as a promising alternative for conventional activated sludge treatment.
Complete retention of the biosolids by the membrane (the so-called "bacteria behind membranes" concept) enables high mixed liquor suspended solids (MLSS) concentrations can be achieved resulting in overall lower sludge treatment costs (Yoon et al. 2004 ). 
Post-treatment technologies
As can be derived from Table 2, There is a need to develop a matrix of treatment scenarios for hospital wastewaters, both with respect to attainable efficiency and costs per m 3 of water treated.
Technologists and economists should be encouraged to develop and calibrate different operational configurations, thus generating the potential for practitioners to be informed on financial aspects and overall risks associated with putative treatments of hospital wastewaters.
